Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System
β Scribed by Kishimoto, Takashi Kei (author);Viswanathan, Karthik (author);Ganguly, Tanmoy (author);Elankumaran, Subbiah (author);Smith, Sean (author);Pelzer, Kevin (author);Lansing, Jonathan C. (author);Sriranganathan, Nammalwar (author);Zhao, Ganlin (author);Galcheva-Gargova, Zoya (author);Al-Hakim, Ali (author);Bailey, Gregory Scott (author);Fraser, Blair (author);Roy, Sucharita (author);Rogers-Cotrone, Thomas (author);Buhse, Lucinda (author);Whary, Mark (author);Fox, James (author);Nasr, Moheb (author);Dal Pan, Gerald J. (author);Shriver, Zachary (author);Langer, Robert S. (author);Venkataraman, Ganesh (author);Austen, K. Frank (author);Woodcock, Janet (author);Sasisekharan, Ram (author)
- Book ID
- 111656930
- Publisher
- Massachusetts Medical Society
- Year
- 2008
- Tongue
- English
- Weight
- 335 KB
- Volume
- 358
- Category
- Article
- ISSN
- 0096-6762
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The interactions of antithrombin (AT) and the contact phase clotting factors with two commercially available heparinized surfaces are reported. The Carmeda (CBAS) and Corline surfaces along with controls (a sulfonated polyethylene surface and a CBAS analog in which the heparin used was